Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in URGN — UroGen Pharma Ltd.

CIK 1037389 NEW YORK, NY
Back to URGN Full portfolio

Position in URGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,587,040
-$3,134,466 QoQ
Shares Held
70,300
-71.2% QoQ
Ownership
0.144%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 190 holders
Holding Since
Dec 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,950,489,724 across 311 Biotechnology names. URGN ranks #115 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 EXEL
Exelixis, Inc.
 13,427,993 $730,617,099
2 CORT
Corcept Therapeutics Inc
 5,261,628 $457,498,554
3 INCY
Incyte Corp
 3,512,132 $398,135,283
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 320,008 $158,957,573
5 JAZZ
Jazz Pharmaceuticals plc
 562,073 $135,442,730
6 RPRX
Royalty Pharma plc
 1,935,800 $108,540,306
7 TVTX
Travere Therapeutics, Inc.
 1,833,079 $104,137,217
8 GMAB
Genmab A/S
 3,517,850 $96,635,339

All Filings in URGN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,587,040 70,300
2025-12-31 $5,721,506 244,300
2025-09-30 $5,488,245 275,100
2025-06-30 $523,340 38,200
2025-03-31 $1,002,036 90,600
2024-12-31 $1,471,830 138,200
2023-12-31 $1,369,500 91,300
2023-09-30 $2,245,803 160,300
2023-06-30 $765,900 74,000
2023-03-31 $443,520 48,000
2022-12-31 $384,071 43,300
2022-09-30 $358,592 43,100
2022-06-30 $357,084 43,600
2022-03-31 $215,137 24,700
2020-12-31 $591,056 32,800